Advertisement

Topics

The National Multiple Sclerosis Society Company Profile

09:23 EDT 24th September 2018 | BioPortfolio

The National MS Society addresses the challenges of each person affected by MS by funding cutting edge research, driving change through advocacy, facilitating professional education, collaborating with MS organizations around the world, and providing programs and services designed to help people with MS and their families move their lives forward. In 2008 alone, through the national office and 50 state network of chapters, the Society devoted over $136 million to programs that enhanced more than one million lives. The Society also invested nearly $50 million to support 440 research projects around the world. To learn more about MS and the Society visit www.nationalMSsociety.org.


News Articles [1824 Associated News Articles listed on BioPortfolio]

Dr. Silvana Costa of Kessler Foundation awarded National MS Society Grant

(Kessler Foundation) Silvana Costa, PhD, has won a $477,000 grant from the National Multiple Sclerosis Society (NMSS) to study the impact of visual, cognitive, and motor deficits on information proces...

MS Society launches petition against NICE’s rejection of Ocrevus

The MS Society has launched a petition imploring the National Institute for Health and Care Excellence, NHS England and Roche to come to an agreement on NHS availability of Ocrevus for primary progres...

NICE Approves Multiple Sclerosis Drugs After Prices Are Reduced

NewsReductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.

How drugs could repair damage from multiple sclerosis

Drugs that help repair the nerve cell lining that’s damaged in multiple sclerosis were found to target certain enzymes. The finding could help researchers develop new treatments for multiple scleros...

Multiple sclerosis drug slows brain shrinkage in NIH-funded trial

A new brain imaging clinical trial funded by the National Institutes of Health (NIH) has showed that multiple sclerosis drug...Read More... The post Multiple sclerosis drug slows brain shrinkage in NI...

[Articles] Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

We propose that myelocortical multiple sclerosis is a subtype of multiple sclerosis that is characterised by demyelination of spinal cord and cerebral cortex but not of cerebral white matter. Cortical...

First clues to the causes of multiple sclerosis

Multiple sclerosis, which affects 1 in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locom...

[Comment] Natalizumab in secondary progressive multiple sclerosis

Although several disease-modifying treatments are available for relapsing types of multiple sclerosis, additional treatment options for progressive types of multiple sclerosis are needed, especially s...

Drugs and Medications [124 Associated Drugs and Medications listed on BioPortfolio]

Monk [National Towelette Company ]

Image of Label

Tysabri [Elan Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection for intravenous useIniti...

Joint formula 88 max [Sarati International, Inc.]

Instant hand sanitizer foam [National Distribution & Contracting, Inc.]

Drug Facts

Antibacterial hand sanitizer pocket sprayer [National Pen Co., LLC]

ANTIBACTERIAL HAND SANITIZER POCKET SPRAYER

PubMed Articles [3601 Associated PubMed Articles listed on BioPortfolio]

Structural MRI Correlates of Cognitive Event-Related Potentials in Multiple Sclerosis.

Cognitive impairment in multiple sclerosis has been associated with cognitive event-related potentials and MRI abnormalities. This study aims to explore for the first time the association between P300...

The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaire.

Cognitive problems are difficult to identify in patients with multiple sclerosis (MS).

Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials.

Progression is the major driver of disability and cost in multiple sclerosis (MS). However, the search for treatments in progressive multiple sclerosis (PMS) has not mirrored the success in relapsing ...

Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry.

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease. Over time, symptoms accumulate leading to increased disability of patients.

Predicting the profile of increasing disability in multiple sclerosis.

Effective therapeutic strategies to preserve function and delay progression in multiple sclerosis (MS) require early recognition of individual disease trajectories.

Clinical Trials [5562 Associated Clinical Trials listed on BioPortfolio]

Swiss Multiple Sclerosis Registry

The Swiss Multiple Sclerosis Registry is a national, patient-centered registry with the aim to document the epidemiology of multiple sclerosis (MS), as well as the quality of life of perso...

National Multiple Sclerosis Society (NMSS) Pilot Study of Transcranial Direct Current Stimulation (tDCS)

This study will test the tolerability and preliminary efficacy of transcranial direct current stimulation (tDCS) combined with a cognitive training program, remotely-delivered using a tele...

A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis

The purpose of this study is to compare two different educational programs for people with multiple sclerosis (MS), which is a common and often disabling disease of the central nervous sys...

Auditory Function in Patients With and Without Multiple Sclerosis

We propose to evaluate auditory function and neuropsychologic function in 150 Multiple Sclerosis (MS) patients and in 150 patients who do not have MS. Experimental subjects will be recrui...

Levetiracetam in Central Pain in Multiple Sclerosis(MS)

Multiple sclerosis is often associated with pain. There is no standard treatment of this type of pain. Levetiracetam is a new anticonvulsant and it is the hypothesis that it could relieve ...

Companies [2460 Associated Companies listed on BioPortfolio]

The National Multiple Sclerosis Society

The National MS Society addresses the challenges of each person affected by MS by funding cutting edge research, driving change through advocacy, facilitating professional education, collaborating wit...

National Multiple Sclerosis Society Utah-Southern Idaho Chapter

MS stops people from moving. The National MS Society exists to make sure it doesn’t. The Society addresses the challenges of each person affected by MS by funding cutting-edg...

National Multiple Sclerosis Society: Lone Star

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body.Â...

Familia Unida

Familia Unida living with Multiple Sclerosis (FULWMS) is the first bilingual, English/Spanish Multiple Sclerosis non-profit organization. It serves over thousands of individuals and families affected...

Jack S. Burks, MD

Jack Burks, MD is a neurologist, researcher, author, and one of the foremost authorities in Multiple Sclerosis who lectures and consults internationally on Multiple Sclerosis research and patient care...

More Information about "The National Multiple Sclerosis Society" on BioPortfolio

We have published hundreds of The National Multiple Sclerosis Society news stories on BioPortfolio along with dozens of The National Multiple Sclerosis Society Clinical Trials and PubMed Articles about The National Multiple Sclerosis Society for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The National Multiple Sclerosis Society Companies in our database. You can also find out about relevant The National Multiple Sclerosis Society Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record